| The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers | The Effects of One-Time Pregnenolone, DHEA, Or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers | NCT00900900 |
| Detection of Dehydroepiandrosterone (DHEA) Augmentation Doping: Pilot Study | Open, non-randomized interventional study in healthy adult volunteers to obtain blood and urine samples for steroid analysis: To identify the serum and urine changes in the androgen profile in (a) men administered DHEA with and without pregnenolone and (b) women administered DHEA with and without anti-estrogens. | ACTRN12611000042943 |
| Effect of DHEA on Patients With Poor Ovarian Responds | Effect of Dehydroepiandrosterone on Live Birth Rate in Subfertile Patients With Poor Ovarian Responds | NCT02432248 |
| A randomised, double blind, placebo-controlled study of the effects of Dehydroepiandrosterone (DHEA) replacement on vascular function in patients with primary and secondary adrenal insufficiency | A randomised, double blind, placebo-controlled study of the effects of Dehydroepiandrosterone (DHEA) replacement on vascular function in patients with primary and secondary adrenal insufficiency | ISRCTN46268487 |
| The role of hormones in acute coronary syndrome (heart attack) | Significance of dehydroepiandrosterone-sulfate and gonadal sex hormones in acute coronary syndrome - sex-based differences | ISRCTN62480360 |
| Dehydroepiandrosterone Maintain Mitochondrial Quality of Cumulus Cells in Poor Ovarian Responders | The Role of Dehydroepiandrosterone in the Maintenance of Mitochondrial Quality of Cumulus Cells in Poor Ovarian Responders | NCT03438812 |
| Establishing a dose of hormone supplementation in trauma patients that will increase hormone levels in the body | A prospective, phase II, single centre, cross-sectional, randomised trial investigating Dehydroepiandrosterone and it's Pharmacokinetics in Trauma - A Dehydroepiandrosterone and Pharmacokinetics in Trauma study (ADaPT) | EUCTR2016-004250-15-GB |
| Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA) | Prospective, Randomized, Open-label and Comparative Study to Determine the Pharmacokinetic Parameters of Vaginal Rings That Contain DHEA, Testosterone, or the Combination of Both Androgens, in Comparison With Oral Administration of DHEA and Transdermal Administration of Testosterone, in Postmenopausal Women | NCT03967964 |
| Does DHEA IVF Outcomes in Poor Responders? | Does Dehydroepiandrosterone (DHEA) Improve IVF Outcomes in Poor Responders? A Randomised, Double-blind, Placebo Controlled Trial | NCT04066478 |
| Role of a natural hormone supplement in improving pregnancy rate. | Dehydroepiandrosterone ( DHEA) role in enhancement and maintenance of implantation (DREAM) - Randomized Double Blind Placebo Controlled Trial - DREAM TRIAL | CTRI/2020/06/025918 |
| Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors | Comparison of Vaginal Dehydroepiandrosterone (DHEA) to Control for Treatment of Vaginal Symptoms in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors: A Phase II Randomized Trial | NCT04493333 |
| Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency | | NCT00004313 |
| The effect Dehydroepiandrosterone (DHEA) supplementation on IVF outcome | The effect Dehydroepiandrosterone (DHEA) supplementation on IVF outcome | IRCT20160523028008N14 |
| The application of Bu-Shen-Ning-Xin decoction combined with dehydroepiandrosterone therapy in postmenopausal osteoporosis | The application of Bu-Shen-Ning-Xin decoction combined with dehydroepiandrosterone therapy in postmenopausal osteoporosis | ITMCTR2200005743 |
| The Outcome of Chinese Women With Genitourinary Syndrome of Menopause Treated With Vaginal Dehydroepiandrosterone | A Review on the Clinical Outcome of Chinese Women With Moderate to Severe Symptoms of Genitourinary Syndrome of Menopause (GSM) Treated With Vaginal Dehydroepiandrosterone (DHEA) | NCT05434351 |
| The effect of dehydroepiandrosterone vaginal tablets in ripening cervical preparation for labor and the process of labor | A comparative study of the effect of dehydroepiandrosterone (DHEA) plus misoprostol with misoprostol alone in accelerating of cervical ripening for delivery and its process in nulliparous women in Akbarabadi Hospital from 2023 to 2025 | IRCT20230722058884N2 |
| The effect vitamin C supplementation on infertile women with polycystic ovary syndrome | The comparison of the effectiveness of vitamin C supplementation with balance diet, versus Placebo on the Luteinizing hormone, follicle-stimulating hormone, Dehydroepiandrosterone, testosterone, estradiol, progesterone and sex hormone-binding protein in infertile women with polycystic ovary syndrome | IRCT2013030312672N1 |
| Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients | Dehydroepiandrosterone Treatment for Poor Responders in IVF Patients: A Prospective Randomised Controlled Trial. | NCT01535872 |
| Dehydroepiandrosterone (DHEA) replacement in patients with secondary adrenal insufficiency (hypopituitarism) | Dehydroepiandrosterone (DHEA) replacement in patients with secondary adrenal insufficiency (hypopituitarism) | ISRCTN14203656 |
| A study to evaluate the effect of fenugreek seed in patients with Polycystic ovary syndrome (PCOS). | The mechanisms involved in the action of Furostanolic saponins (Furocyst) in regulating ovarian function in the dehydroepiandrosterone [DHEA] induced polycystic ovary of mouse and its clinical outcomes. | CTRI/2020/02/023360 |
| The application of Bu-Shen-Ning-Xin decoction combined with dehydroepiandrosterone therapy in postmenopausal osteoporosis | The application of Bu-Shen-Ning-Xin decoction combined with dehydroepiandrosterone therapy in postmenopausal osteoporosis | ChiCTR2100048647 |
| DHEA Treatment for Sjogren's Syndrome | Dehydroepiandrosterone (DHEA) Treatment for Sjogren's Syndrome | NCT00001598 |
| Treatment of Mid-Life-Related Mood Disorders | Dehydroepiandrosterone Treatment of Mid-Life-Related Mood Disorders in Women and Men | NCT00001487 |
| Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus | | NCT00004665 |
| DHEA hormone to treat ovarian aging | Efficacy of Dehydroepiandrosterone to overcome the effect of ovarian aging - DHEA Intervention To Treat Ovarian aging | EUCTR2011-002425-21-GB |
| Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment | | NCT01145144 |
| Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF) | A Randomized Double Blinded Trail of DHEA Supplementation for Treatment of Couples With Premature Ovarian Failure (POF). | NCT00948857 |
| Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder | Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder: Modulation of Sexual Libido by Androgens and Neurosteroids | NCT00916396 |
| A double-blind, placebo-controlled, randomised, N=1 study to determine the effect of concomitant treatment with dehydroepiandrosterone (50 mg) on mood in women who experience mood disturbances during oral contraception-use. - ARC-MOOD | A double-blind, placebo-controlled, randomised, N=1 study to determine the effect of concomitant treatment with dehydroepiandrosterone (50 mg) on mood in women who experience mood disturbances during oral contraception-use. - ARC-MOOD | EUCTR2008-004569-24-NL |
| Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility | A Randomized Double Blinded Trail of DHEA Supplementation for Treatment of Couples With Normal Hysterosalpingogram and Normal Semen Analysis and Evidence of Premature Ovarian Aging (POA). | NCT00650754 |
| A double-blind, placebo-controlled, randomized, N=1 study to determine the effect of concomitant treatment with dehydroepiandrosterone (50 mg) on sexual functioning in 6 women who experience a decrease in sexual functioning due to their oral contraception-use. - ARC-SOLO | A double-blind, placebo-controlled, randomized, N=1 study to determine the effect of concomitant treatment with dehydroepiandrosterone (50 mg) on sexual functioning in 6 women who experience a decrease in sexual functioning due to their oral contraception-use. - ARC-SOLO | EUCTR2007-007620-17-NL |
| Dehydroepiandrosterone Substitution in Adolescent and Young Women With Central Adrenal Insufficiency | Dehydroepiandrosterone(DHEA) Substitution in Adolescent and Young Women With Central Adrenal Insufficiency. A Multicenter, Randomised Double Blind Trial | NCT00575341 |
| Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria | Etude de l’Activite (Efficacite et Tolerance) de l’Association de la Chloroquine Avec la Dehydroepiandrosterone-Sulfate (Dheas) Dans le Traitement de l’Acces Palustre Simple A Plasmodium Falciparum | NCT00442403 |
| A double-blind, placebo controlled, randomised, comparative 2-way crossover study to determine the effect of concomitant treatment with dehydroepiandrosterone (50 mg) on sexual arousability and the vascular component of the sexual arousal response during self-induced erotic fantasy and visual sexual stimulation in women using oral contraception (150 mcg levonorgestrel and 30 mcg ethinylestradiol or 3 mg drospirenone and 30 mcg ethinylestradiol) - ARC study | A double-blind, placebo controlled, randomised, comparative 2-way crossover study to determine the effect of concomitant treatment with dehydroepiandrosterone (50 mg) on sexual arousability and the vascular component of the sexual arousal response during self-induced erotic fantasy and visual sexual stimulation in women using oral contraception (150 mcg levonorgestrel and 30 mcg ethinylestradiol or 3 mg drospirenone and 30 mcg ethinylestradiol) - ARC study | EUCTR2007-000013-10-NL |
| A Trial of Dehydroepiandrosterone (DHEA) Treatment for in Vitro Fertilization (IVF) | A Randomized Placebo-Controlled Trial of Dehydroepiandrosterone (DHEA) Treatment for Two Months Before Starting Ovulation Induction for in Vitro Fertilization (IVF) | NCT00419913 |
| Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome | Fatigue and General Well-Being in Patients With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome: Effects of Dehydroepiandrosterone Administration | NCT00391924 |
| Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention | Does DHEA Improve Endothelial Dysfunction and Other Cardiovascular Risk Factors in Premenopausal Women With Systemic Lupus? | NCT00189124 |
| Efficacy and Safety of DHEA for Myotonic Dystrophy | Phase 3 Study of Oral Dehydroepiandrosterone (DHEA) in Adults With Myotonic Dystrophy | NCT00167609 |
| Zoetermeer Study. | Double-blind randomised, placebo-controlled clinical study to investigate the effects of daily oral atamestane (100 mg/day) and dehydroepiandrosterone (50 mg/day) alone and in a combined regimen on physical frailty and quality of life in 100 elderly male volunteers over a treatment period of 36 weeks. | NL-OMON28735 |
| Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus | | NCT00004662 |
| Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus | | NCT00004795 |
| Effects of Dehydroepiandrosterone on ovary. | Study the effect of Dehydroepiandrosterone on the ovarian reserve rates and serum anti-Mullerian hormone levels in infertile women with diminished ovarian reserve. | IRCT2017091529374N1 |
| ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction | A Randomized Double-Blind Placebo-Controlled Study Comparing the Safety and Efficacy of Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction | NCT00202163 |
| Effects of Dehydroepiandrosterone Supplementation on Cumulus Cells Gene Expression Under Controlled Ovarian Hyper-stimulation in Patients With Diminished Ovarian Reserve | Effects of Dehydroepiandrosterone Supplementation on Cumulus Cells Gene Expression Under Controlled Ovarian Hyper-stimulation in Patients With Diminished Ovarian Reserve | NCT02150330 |
| Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors | Vaginal Prasterone In The Treatment Of Vaginal Atrophy In Patients With Breast Cancer Treatment With Aromatase Inhibitors (Vibra Study) | NCT04705883 |
| Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms | Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial | NCT01376349 |
| Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido | Multi-center, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Daily Oral 100 mg Dehydroepiandrosterone (DHEA) Over 6 Treatment Cycles as a Concomitant Therapy to Oral Contraceptives (OC) to Alleviate Complaints of Reduced Libido in Women With Acquired Female Sexual Dysfunction (FSD) Associated With OC-use | NCT00566384 |
| Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma | A Phase II Clinical Trial of Dehydroepiandrosterone and Biaxin in Monoclonal Gammopathy of Undetermined and Borderline Significance | NCT00006219 |
| Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain | Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain | NCT04898556 |
| Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women | A Randomized, Double-blind, Placebo-controlled Trial on the Preventive Effect of Intravaginal Prasterone (DHEA, Intrarosa®) on Recurrent Urinary Tract Infections in Women With Genitourinary Syndrome of Menopause | NCT03854396 |
| Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer | Effect of Intravaginal Prasterone (DHEA) on Moderate to Severe Symptoms of Vulvovaginal Atrophy Due to Menopause, in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer - (Placebo-Controlled, Double Blind and Randomized Phase III Study) | NCT03740945 |
| Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study | Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study (Placebo-Controlled, Double-Blind and Randomized Phase III Study of Intravaginal Prasterone) | NCT03619005 |
| A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal Atrophy | A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase ?, Efficacy and Safety Study of INTRAROSA® (Prasterone) Vaginal Inserts on Postmenopausal Vulvovaginal Atrophy (VVA) | NCT04982692 |
| Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia | Open-Label Vulvoscopy Photography Study of Changes in Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Administration of 6.5 Mg Vaginal Prasterone in Menopausal Women With Moderate to Severe Dyspareunia | NCT03568604 |
| Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) | Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone) | NCT03287232 |
| Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause | | NCT02013544 |
| A double-blind, placebo controlled, randomized, comparative, mono-centre trial to assess the effects on the androgen metabolism and its effects on biochemical parameters, mood, fat, muscle and bone of continuous supplementation with dehydroepiandrosterone in women using a monophasic contraception containing drospirenone and ethinylestradiol - AMUSA | A double-blind, placebo controlled, randomized, comparative, mono-centre trial to assess the effects on the androgen metabolism and its effects on biochemical parameters, mood, fat, muscle and bone of continuous supplementation with dehydroepiandrosterone in women using a monophasic contraception containing drospirenone and ethinylestradiol - AMUSA | EUCTR2007-003788-28-BE |
| The Effect of a Higher Dose of Dehydroepiandrosterone (DHEA) Supplementation in Poor Responders | The Effect of a Higher Dose of Dehydroepiandrosterone (DHEA) Supplementation on the Number of Oocytes Obtained During IVF in Poor Ovarian Responders | NCT02357472 |
| Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast Cancer | Effect of Intravaginal Prasterone on Genitourinary Syndrome in Women in Menopause With Previous Breast Cancer or Currently Under Treatment With Endocrine Therapy for Breast Cancer With Aromatase Inhibitor +/- LHRHa | NCT06611514 |
